z-logo
open-access-imgOpen Access
Rationale, Design and Early Trial Performance of AOSpine North America Multi-Center Double Blind Randomized Controlled Trial of Safety and Efficacy of Riluzole in CSM (CSM – Protect Trial)
Author(s) -
Michael G. Fehlings,
Branko Kopjar
Publication year - 2016
Publication title -
global spine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.398
H-Index - 26
eISSN - 2192-5690
pISSN - 2192-5682
DOI - 10.1055/s-0036-1583080
Subject(s) - medicine , riluzole , randomized controlled trial , placebo , sample size determination , interim analysis , minimal clinically important difference , clinical trial , anesthesia , physical therapy , surgery , amyotrophic lateral sclerosis , disease , statistics , alternative medicine , mathematics , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here